| IVP 0.082 256.52% | OCG 0.0118 4.42% | SOXS 2.28 0.48% | SEGG 0.9267 79.91% | ZSL 2.82 -14.80% | MTEN 0.0353 4.75% | SLV 84.56 7.58% | SAFX 0.1373 -17.74% | NVDA 183.14 -1.44% | INTC 48.72 3.02% | ASST 1.03 6.19% | TZA 6.16 -1.99% | TQQQ 53.83 -3.18% | JTAI 0.4546 13.65% | DVLT 0.7182 -10.33% | SPY 690.36 -0.49% | PSTV 0.2904 -38.23% | BBAI 6.26 2.79% | IBIT 55.44 3.49% | ONDS 13.56 -2.38% | MSTX 5.2 7.22% | PLUG 2.35 3.07% | ROLR 18.89 436.65% | XLE 48.06 2.26% | QQQ 619.55 -1.07% | TSLL 18.07 -3.58% | BAC 52.48 -3.78% | SOXL 55.38 -1.23% | ASBP 0.0587 -26.44% | BMNR 32.68 4.68% | BITO 13.56 3.39% | TSLS 5.19 1.76% | DUST 5.8 -0.68% | AAL 15.14 -1.37% | BITF 2.94 -5.47% | FNGD 5.51 5.15% | DNN 3.49 4.33% | ACHR 8.91 5.19% | CLSK 13.34 6.29% | F 13.835 -1.04% | JDST 2.11 -0.71% | XLF 54.15 -0.15% | CRML 17.925 32.58% | BEEM 1.87 5.65% | ETHA 25.59 5.66% | TSLA 439.2 -1.79% | OPEN 6.64 -1.92% | MARA 11.11 1.46% | PBR 12.66 2.93% | SIDU 3.75 20.58%

MetLife Inc. (NYSE: MET) Earnings Report Highlights

MetLife Inc. (NYSE: MET) is a leading global provider of insurance, annuities, and employee benefit programs. The company operates in over 40 countries and serves millions of customers worldwide. MetLife competes with other major insurers like Prudential Financial and AIG. On November 5, 2025, MetLife reported its earnings, showcasing a mixed financial performance.

MetLife achieved an earnings per share (EPS) of $2.34, surpassing the estimated $2.31. This positive EPS result reflects the company's strong earnings performance, driven by gains from its investment portfolio. The adjusted earnings per share, excluding notable items, rose by 21% to $2.37, indicating robust growth in its core operations.

Despite the EPS beat, MetLife's revenue fell short of expectations, coming in at $17.36 billion against an estimated $18.64 billion. However, the company's net income for the third quarter was $818 million. This was supported by a 15% increase in adjusted earnings, reaching $1.6 billion, largely due to higher variable investment income and volume growth.

MetLife's financial metrics provide further insight into its performance. The company has a price-to-earnings (P/E) ratio of approximately 12.31, suggesting that investors are willing to pay $12.31 for every dollar of earnings. The price-to-sales ratio is about 0.72, indicating the stock is valued at less than one times its sales, while the enterprise value to sales ratio is around 0.69. The company's financial health is underscored by its debt-to-equity ratio of approximately 0.72, showing a balanced approach to financing its assets. 

Published on: November 6, 2025